In this present study, we aimed to investigate whether prediabetes was interacted with the ABO blood group in the prediction of ESCC-specific mortality among 1,857 normal and prediabetic patients over a 15-year follow-up period. The gene discussed is ABO; the disease is prediabetes syndrome.